BARABE TIMOTHY C

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$95,250.00
Insider Sells Quantity
12
Insider Sells Sum
$2.27M

Insider Activity of BARABE TIMOTHY C

According to the SEC Form 4 filings, BARABE TIMOTHY C, being in a position of

  1. director at Cartesian Therapeutics, Inc.,
    оver the last 12 months, has bought 7500 shares for $95,250, and sold 0 shares,
    over all time since 2024-08-12, has bought 7500 shares for $95,250, and sold 0 shares.

The largest purchase of all time was on 2024-08-12 and amounted to 7500 shares of Cartesian Therapeutics, Inc. for $95,250.

The largest sale of all time was on 2020-10-13 and amounted to 1292 shares of Veeva Systems Inc. for $398,827.

Biography of BARABE TIMOTHY C

No biography is available at this moment.

2024-08-12PurchaseCartesian Therapeutics, Inc.
RNAC
director
7,500
0.0353%
$12.70$95,250+17.13%
2020-10-13SaleVeeva Systems Inc.
VEEV
director
1,292
0.0009%
$308.69$398,827-7.16%
2020-10-08SaleVeeva Systems Inc.
VEEV
director
952
0.0006%
$288.00$274,176-1.4%
2020-06-23SaleVeeva Systems Inc.
VEEV
director
347
0.0002%
$242.00$83,974+13.33%
2020-06-22SaleVeeva Systems Inc.
VEEV
director
1,428
0.0009%
$238.45$340,509+13.4%
2020-04-08SaleVeeva Systems Inc.
VEEV
director
347
0.0002%
$156.00$54,132+65.68%
2019-06-18SaleVeeva Systems Inc.
VEEV
director
727
0.0005%
$167.19$121,549-7.89%
2019-04-02SaleVeeva Systems Inc.
VEEV
director
1,454
0.001%
$127.41$185,247+14.83%
2018-09-27SaleVeeva Systems Inc.
VEEV
director
1,454
0.001%
$105.00$152,670+19.83%
2018-05-31SaleVeeva Systems Inc.
VEEV
director
1,402
0.001%
$77.54$108,711+27.55%
2018-03-08SaleVeeva Systems Inc.
VEEV
director
3,986
0.0028%
$78.16$311,546+12.06%
2017-03-30SaleVeeva Systems Inc.
VEEV
director
2,584
0.0019%
$51.04$131,887+17.44%
2016-12-30SaleVeeva Systems Inc.
VEEV
director
2,584
0.0019%
$40.54$104,759+40.29%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.